Chen Ren
About Chen Ren
Chen Ren is the Associate Scientific Director at Bristol Myers Squibb in Summit, New Jersey, with extensive experience in analytical science and bioanalytical research.
Current Role at Bristol Myers Squibb
Chen Ren currently serves as the Associate Scientific Director at Bristol Myers Squibb in Summit, New Jersey, United States. In this role, he is responsible for overseeing scientific activities and ensuring the quality of analytical processes. Ren's extensive background in analytical chemistry and bioanalytical research equips him with the expertise needed to manage complex scientific projects effectively.
Tenure at Onconova Therapeutics, Inc.
Chen Ren worked at Onconova Therapeutics, Inc. in various capacities from 2008 to 2021, with his roles evolving significantly over the years. He started as a Senior Research Scientist (2008-2013) and later became a Manager, Bioanalytical Research. He then took on the roles of Senior Manager and Director of Analytical Science, accumulating extensive experience in bioanalytical research and analytical science management.
Ph.D. in Analytical Chemistry from The Ohio State University
Chen Ren earned his Ph.D. in Analytical Chemistry from The Ohio State University. His doctoral studies provided him with a robust foundation in analytical techniques and research methodologies. This academic background has been instrumental in his professional roles, enabling him to excel in the field of bioanalytical research and analytical development.
Research Experience at College of Pharmacy, The Ohio State University
Prior to his industry roles, Chen Ren served as a Post-doctoral Researcher at the College of Pharmacy, The Ohio State University from 2006 to 2008. During this period, he gained valuable research experience that laid the groundwork for his subsequent positions in the pharmaceutical sector. His research focused on advanced analytical methods and pharmacokinetic analysis.
Skills in Analytical Methods and Bioanalytical Research
Chen Ren has substantial expertise in the development and validation of various analytical methods, including HPLC, GC, and LC-MS/MS. He is adept at authoring and reviewing CMC dossiers for regulatory submissions and has led the establishment of analytical quality systems to support cGMP manufacturing. His skills also encompass protein identification using advanced techniques such as LC/MS and peptide mass mapping.